Research ArticleCancer

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

See allHide authors and affiliations

Science Translational Medicine  26 Aug 2015:
Vol. 7, Issue 302, pp. 302ra136
DOI: 10.1126/scitranslmed.aac9459
PDF Container

Navigate This Article